Back to Introduction to Drug Hunting
Novartis

Introduction to Drug Hunting

This course introduces and summarizes the different steps of preclinical drug discovery, wrapping up with a brief description of the subsequent clinical trials and the importance of competitive intelligence in project strategy.  It provides a high-level overview for those interested in a more general understanding of the topic and forms the foundation for a more in-depth exploration of topics covered in other courses in this series. Target audience: This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended.

Status: Competitive Intelligence
Status: Drug Development
IntermediateCourse10 hours

Featured reviews

AR

5.0Reviewed Aug 25, 2024

succinct, well explained, quick to move through the modules

TR

5.0Reviewed Nov 21, 2024

Great introduction - accessible and clear, even for a none scientist

MS

5.0Reviewed Sep 20, 2024

I love how concise it is. The structure is incredibly well done. Thank you!

VM

5.0Reviewed Apr 1, 2025

This coarse is really beginner's friendly and easy to understand.

MJ

5.0Reviewed Aug 5, 2025

Very well conducted and provided all basic information in easy language and graphs

HE

5.0Reviewed Oct 7, 2025

Just the right pace and level of detail to support my introductory understanding

SA

5.0Reviewed Aug 29, 2024

Great neatly-packaged and succinct course on drug discovery and development.

All reviews

Showing: 19 of 19

Dave Solis
5.0
Reviewed Oct 23, 2024
I.P
5.0
Reviewed Dec 30, 2025
N VENKATA SAI SREERAM
5.0
Reviewed May 16, 2025
Mrudini Jagtap
5.0
Reviewed Aug 5, 2025
Heidi Ewell
5.0
Reviewed Oct 7, 2025
Sofi V A
5.0
Reviewed Aug 30, 2024
Marta Simões
5.0
Reviewed Sep 20, 2024
Tim Redding
5.0
Reviewed Nov 21, 2024
Vidushi Mishra
5.0
Reviewed Apr 2, 2025
Alexandra Rizzitelli
5.0
Reviewed Aug 25, 2024
JANANI M PSGRKCW
5.0
Reviewed Dec 7, 2024
Arvind chaudhary
5.0
Reviewed Nov 23, 2025
Rasha Nasser
5.0
Reviewed Jul 26, 2024
Federica Iberite
5.0
Reviewed Aug 2, 2024
NGOC-DUY DINH
5.0
Reviewed May 19, 2025
manuel kleponi
5.0
Reviewed Apr 4, 2026
Luigi Negri
5.0
Reviewed May 18, 2025
JIWAN BAE
5.0
Reviewed Dec 3, 2025
Andres Mauricio Olarte Marin
5.0
Reviewed May 28, 2024